Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo
Yahoo Finance · 2 days ago
Open | 40.86 |
High | 41.29 |
Low | 40.70 |
Mkt Cap | 82.87B |
P/E (TTM) | N/A |
Div & Yield | 2.40 & 5.82% |
Prev. Close | 41.24 |
52 Wk. Low | 39.91 |
52 Wk. High | 66.38 |
Related stocks
American pharmaceutical company
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 11.87B | 4.70% ▲ |
Net Income | -11.91B | - |
Diluted EPS | -4.40 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $1.70 | - |
Q1 2024 | -$4.44 | -$4.40 |
Q4 2023 | $1.43 | $1.59 |
S&P 500^GSPC | 5,352.96-1.07 (-0.02%) |
Dow 30^DJI | 38,886.17+78.84 (+0.20%) |
Nasdaq^IXIC | 17,173.12-14.78 (-0.09%) |
46.55+47.45% | |
5.79+12.43% | |
DocuSign, Inc.DOCU | 54.60+1.98% |